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Abstract 
Purpose To evaluate the linguistic and psychometric properties of the 
Functional Living Index – Cancer (FLIC) in assessing the quality of life of Chinese 
cancer patients 
Methods We followed the standard forward-backward procedure to translate the 
original English FLIC into Traditional Chinese. After cognitive debriefing, a 
Traditional Chinese FLIC was administered to 500 cancer patients in a major public 
hospital in Hong Kong. Of which, 200 were invited to complete the questionnaire in 2 
weeks. Exploratory and confirmatory factor analyses were performed on two 
randomly split halves of the sample to identify a scale structure appropriate to 
Chinese. 
Results  We identified five scales of the Traditional Chinese FLIC which assess 
the physical, psychological, hardship, nausea and social aspects. These five scales and 
the overall scale demonstrated satisfactory fit in the independent halve of the sample, 
and had the alpha coefficient ranged from 0.68 to 0.92. The intraclass correlation 
coefficient ranged from 0.67 to 0.88. In addition, all FLIC scales were negatively 
associated with the Eastern Cooperative Oncology Group performance status and also 
except the psychological scale had lower scores in patients who were treated by 
chemotherapy.  
Conclusions The Traditional Chinese FLIC is an appropriate health indicator for 
Chinese cancer patients. 
 
Keywords Cancer; Chinese; FLIC; psychometric; reliability; validity 
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Abbreviations 
CFA Confirmatory factor analysis 
ECOG Eastern Cooperative Oncology Group 
EFA Exploratory factor analysis 
EORTC QLQ European Organisation for Research and Treatment of Cancer 
Quality of Life Questionnaire  
FACT-G Functional Assessment of Cancer Therapy-General 
FLIC Functional Living Index – Cancer 
ICC Intraclass correlation coefficient 
RMSEA Root mean square error of approximation 
SD Standard deviation 
SRMR Standardized root mean square residual 
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Introduction 
Both survival and quality of life have been considered as important outcomes in 
cancer trials [1]. The 22-item Functional Living Index–Cancer (FLIC) is a cancer 
specific quality of life instrument [2] with emphasis on the extent cancer and its 
related treatments affected patients’ normal functions. It has good coverage of 
relevant aspects of quality of life [2,3], with good discriminative ability and high 
sensitivity [4-6]. Despite these, a properly tested Traditional Chinese FLIC had been 
unavailable. The Traditional Chinese has been a main written language in Guangzhou, 
Hong Kong, Macau and Taiwan, covering over 36 million people in 2012. Hence, the 
development of FLIC in Traditional Chinese is desirable. Moreover, the FLIC had 
varied scale structures reported [5,4,7,2,8] (Table 1), and their appropriateness had not 
been assessed.  
Therefore, this study aimed to culturally adapt the FLIC in Traditional Chinese 
and assess the appropriateness of its scale structures identified in the literature. 
 
Methods 
Linguistic validation 
Two professional translators independently translated the English FLIC into 
Traditional Chinese. A consensus meeting comprising the two translators and two 
authors [DF, AL] was then convened to obtain a census Chinese version. Its back-
translated version, by a third professional translator, was compared with the original 
English version by [DF, AL] and a clinical oncologist [YC]. The revised Chinese 
version was then tested in five Chinese adult cancer patients after seeking their 
written consent. The patients were debriefed for the clarity and relevance by 
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responding on a 5-point Likert scale. Ethics approval of the study was sought from 
recognized local ethics committees. 
 
Psychometric evaluation 
Subjects 
500 cancer patients visiting an outpatient oncology department in Hong Kong who 
were 18 years or older and literate in Traditional Chinese were recruited with 
informed consent. The sample size was based on the use of exploratory/confirmatory 
factor analyses on two randomly split halves of the sample, by the usual rule of 10 
subjects per item for a factor analysis. Ethics approval of the study was also sought 
from ethics committees. 
 
Measurements and Procedures 
All consented patients self-completed the Traditional Chinese FLIC. We also obtained 
their demographics, medical history and the Eastern Cooperative Oncology Group 
(ECOG) performance status [9]. 200 patients were randomly selected, and asked to 
complete the Traditional Chinese FLIC again as well as also five global rating scales 
on whether they had significant change in physical health, emotional health, social life, 
family hardship and nausea since last clinical visit in 7-14 days after their first 
completion.  
 
Statistical Analysis 
We randomly split the sample into two halves with 248 in a training set and 252 in a 
validation set [10]. The training set was used to perform an exploratory factor analysis 
(EFA) with the number of factors determined by scree plot and factor loadings 
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estimated by maximum likelihood after a promax rotation [11].  The identified factor 
structure was then assessed in the validation set by confirmatory factory analysis 
(CFA). Goodness-of-fit was assessed by the root mean square error of approximation 
(RMSEA), standardized root mean square residual (SRMR), and the Bollen 2 [12]. A 
CFA model was considered acceptable when RMSEA is close to 0.06 or below, 
SRMR is close to 0.08 or below, and Bollen 2 is close to 0.95 or greater [13]. A 
second order scale structure incorporating the overall factor was also fitted to assess 
the adequacy of having the overall scale. The same CFA analysis was used to assess 
the fit of scale structures reported in the literature [2,4,7,5,8]. Our identified scale 
structure was further assessed for its internal consistency by calculating the 
Cronbach’s alpha, and its clinical validity by examining the hypothesized negative 
association with the ECOG performance status and the experience of chemotherapy 
using regression analysis.   
Test-retest reliability was assessed by the intraclass correlation coefficient 
(ICC) based on patients who reported no significant change in all the global rating 
scales in the retest. 
The Statistical Analysis System (SAS) was used for the analysis (SAS 
Institute, Cary, NC, US).  
 
Results 
Cognitive Debriefing 
The five (three females) patients had age ranged between 44 to 60 years, and either 
breast, renal, sigmoid colon, lung or nasopharyngeal cancer. The median completion 
time of the Traditional Chinese FLIC was 3 minutes (range = 2 to 9 minutes). All 
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patients considered the length of instrument acceptable. The median relevance rating 
was moderate and that for clarity was high.  
 
Psychometric Validation 
The training and validation sets had no significant differences (Table 2). Using the 
training set, EFA identified five factors, namely physical, psychological, hardship, 
nausea and social (Table 1). Their between-scale correlation ranged from 0.29 to 0.47. 
Using the validation set, the EFA derived 5-factor structure and those previously 
identified factor structures had satisfactory fit although the EFA derived model 
slightly fitted better than the others (Table 1).  The second order models did not 
substantially deteriorate the fit indices. 
 All scales had small floor and ceiling effects, with only the nausea and social 
scales exhibited high ceiling effects (Table 3). A significant negative association was 
identified in all scales, except for the insignificant association between the 
psychological scale and experience of chemotherapy. 
 155 (78%) patients completed the re-test and returned the questionnaires by 
post. Of which, 49 patients reported no significant change in all the global rating 
scales since the last visit; based on which, the ICCs were satisfactory (Table 3). 
 
Discussions 
The reasons of differential factor structures reported in the literature may be three-
folded. First, several factor structures were identified from an EFA after a varimax 
rotation [4,7,2], which constraints the factors to be uncorrelated; but then there 
appeared moderate correlation among the five factors identified in our EFA and also 
in Ruckdeschel & Piantadosi [8]. Second, EFA was conducted on samples of size 
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ranged from 84 to 438 but a small sample size may yield an unstable factor structure. 
Third, there could be cultural difference in conceptualization of quality of life; even 
the English version when administered in Singapore showed a factor structure 
different from those reported in Australia and North America. 
The scale structure of the Traditional Chinese FLIC closely resembles to those 
reported by the original developer and Ruckdeschel & Piantadosi [2,8]. Indeed, our 
CFA shows all three factor structures had satisfactory model fit. They may all be 
validly used in Chinese. 
Both the nausea and social scales had high ceiling effects, with around 50% of 
patients had no nausea or social concern. Nausea and reduced willingness to social in 
cancer patients would be mainly induced by chemotherapy. In our validation sample, 
138 (55%) either had not had chemotherapy or had completed chemotherapy for at 
least six months; which may have contributed to the high ceiling effects.  
 The internal consistency of the Traditional Chinese FLIC with Cronbach’s 
alpha ranged between 0.68 and 0.92 is satisfactory according to the criteria of 0.7 
suggested by Nunnally [14]. They are comparable to those reported in the original 
English (range: 0.64 to 0.87), and the Simplified Chinese (range: 0.57 to 0.92) 
versions [15-17]. In addition, to our knowledge, only the Simplified Chinese FLIC 
had its test-retest reliability assessed with the reliability coefficient for its overall scale 
as 0.78 [6]. The 2-week test-retest reliability of the Traditional Chinese FLIC is 
satisfactory.  
 Our study is however limited to patients with good performance status. 
Patients with poorer health status may tend to not participate. Exclusion of them 
would attenuate the association between the FLIC scales and the ECOG performance 
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status. However, the clear supporting evidence of their associations indicating a good 
clinical validity of the FLIC. 
 
Conclusion 
The overall and five scales of the Traditional Chinese FLIC are reliable and valid for 
assessing the quality of life of cancer patients. 
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Table 1 Factor structures of the Functional Living Index-Cancer (FLIC) 
Item 
No. 
 
Goh et al. (1996)
[Singaporean – 
Chinese] 
(n=84) 
Goh et al. (1996)
[Singaporean – 
English] 
(n=124) 
King et al. (1996)
[Australian] 
(n=98) 
Morrow et al. 
(1992) 
[American] 
(n=244) 
Ruckdeschel & 
Piantados (1991)
[American] 
(n=438) 
Schipper et al. 
(1984) 
[Canadian] 
(n=175) 
Factor loadings from  
exploratory factor analysis 
[Traditional Chinese] 
Items in FLIC 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 1 2 3 4 5 
15. Able to complete housework?          0.52     
4. Maintain leisure activities?          0.36     
7. Well enough for meals or repairs?          0.75     
10. Satisfied with work?           0.49     
13. Pain/discomfort interfering activities?           0.62   
20. Pain/discomfort related to cancer?            0.54   
11. Feel uncomfortable?        0.56     
22. Appear well?          0.71     
6. Feel well?          0.62     
18. Frightened of future?          0.50    
9. Discouraged about life?          0.73    
3. Think about illness?           0.27    
2. Cope well with stress?          0.42    
1. Feel depressed?          0.56    
21. Confident of treatment?           0.29    
12. Disruptive to the closest?           0.49   
8. Hardship on the closest?            0.51   
14. Hardship on yourself?           0.71   
5. Nausea affecting daily functioning?             0.39  
17. How much nausea?              0.98  
16. Willing to spend time with family?               0.62 
19. Willing to spend time with friends?              0.77 
Fit indices in confirmatory factor analysis 
(First order model/Second order model) 
        
 2 (degrees of freedom) 394.6 (192) / 
424.2 (192)  
368.4 (190) / 
390.6 (190) 
364.1 (192) / 
378.5 (192) 
384.8 (193) / 
389.0 (193) 
361.8 (194) / 
392.3 (194) 
347.0 (191) / 
372.9 (191) 
340.2 (192) / 366.3 (192) 
 RMSEA 0.067 / 0.071 0.063 / 0.067 0.062 / 0.064 0.065 / 0.066 0.061 / 0.066 0.059 / 0.064 0.057 / 0.062 
 SRMR 0.063 / 0.067 0.065 / 0.063 0.059 / 0.061 0.061 / 0.061 0.054 / 0.059 0.055 / 0.058  0.057 / 0.60 
 Bollen 2 0.91 / 0.90 0.92 / 0.91 0.92 / 0.92 0.92 / 0.91 0.93 / 0.91 0.93 / 0.92 0.94 / 0.92 
RMSEA = root mean square error of approximation 
SRMR = standardized root mean square residual 
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Table 2 Sample characteristics 
 
Training set 
(n = 248) 
Validation set 
(n = 252) 
 
Characteristics n % n % p-value 
Age (years) 
mean±SD 
 
49.0±10.2 
 
50.2±9.8 
0.140 
Gender 
Female 
Male 
 
153 
95 
 
61.7 
38.3 
 
161 
91 
 
63.9 
36.1 
0.653 
Marital status (missing: n = 4) 
Single 
Married or cohabitated 
Widowed or separated 
 
34 
180 
32 
 
13.8 
73.2 
13.0 
 
37 
185 
28 
 
14.8 
74.0 
11.2 
0.346 
Education (missing: n = 1) 
Primary or below 
Secondary 
College 
Tertiary or above 
 
74 
148 
11 
14 
 
30.0 
59.9 
4.5 
5.7 
 
74 
145 
13 
20 
 
29.4 
57.5 
5.2 
7.9 
0.751 
Recurrence (missing: n = 10) 
No 
Yes 
 
218 
24 
 
90.1 
9.9 
 
227 
21 
 
91.5 
8.5 
0.648 
Diagnosis  
Breast 
Digestive 
Gynecological 
Lung 
Nasopharyngeal 
Thyroid 
Others 
 
64 
51 
27 
26 
31 
27 
22 
 
25.8 
20.6 
10.9 
10.5 
12.5 
10.9 
8.9 
 
71 
43 
32 
19 
40 
20 
27 
 
28.2 
17.1 
12.7 
7.5 
15.9 
7.9 
10.7 
0.516 
ECOG performance status 
0 
1 
2 
3 
4 
 
90 
143 
11 
3 
1 
 
36.3 
57.7 
4.4 
1.2 
0.4 
 
87 
149 
10 
6 
0 
 
34.5 
59.1 
4.0 
2.4 
0 
0.773 
On or completed chemotherapy 
No 
Yes 
 
84 
164 
 
33.9 
66.1 
 
82 
170 
 
32.5 
67.5 
0.776 
Duration of diagnosis (years) 
mean±SD 
 
2.9±5.9 
 
2.6±3.8 
0.900 
ECOG  Eastern Cooperative Oncology Group  
SD  Standard deviation 
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Table 3 Scale summary and clinical validity of the FLIC in the validation set 
       ECOG Experience of chemotherapy  
FLIC scales (No. 
of items) n Mean±SD Range 
% 
Floor
% 
Ceiling
Cronbach’s 
alpha 
Regression coefficient 
(95% CI) 
p-
value
Regression coefficient 
(95% CI) p-value ICC 
Overall (22) 251 71.5±18.3 9.1-100 0 2.8 0.92 -11.9 (-15.1, -8.7) <0.001 -7.8 (-12.5, -3.0) 0.002 0.83 
Physical (7) 251 73.9±20.2 14.3-100 0 10.0 0.84 -13.2 (-16.7, -9.7) <0.001 -7.4 (-12.6, -2.1) 0.006 0.70 
Psychological (6) 251 68.5±20.7 0-100 0.4 8.4 0.80 -5.8 (-9.7, -1.83) 0.004 -1.1 (-6.6, 4.3) 0.682 0.67 
Hardship (5) 251 64.1±25.9 0-100 1.6 10.4 0.82 -16.1 (-18.6, -9.7) <0.001 -14.0 (-20.6, -7.3) <0.001 0.86 
Nausea (2) 250 82.0±25.0 0-100 0.8 51.2 0.68 -14.1 (-18.6, -9.7) <0.001 -13.3 (-19.7, -6.9) <0.001 0.88 
Social (2) 251 80.7±26.2 0-100 2.0 49.4 0.73 -12.5 (-17.3, -7.7) <0.001 -8.3 (-15.1, -1.4) 0.019 0.74 
CI Confidence interval 
ECOG  Eastern Cooperative Oncology Group  
ICC Intraclass correlation coefficient 
SD  Standard deviation 
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Fig. 1 Standardized estimates of a second order factor model in the validation set 
 
 
